Overview

Modafinil for Atypical Depression

Status:
Completed
Trial end date:
2005-04-01
Target enrollment:
Participant gender:
Summary
The purposes of the study are to: 1) evaluate the short-term efficacy and safety of modafinil in atypical depression; and 2) to evaluate the efficacy of modafinil in preventing relapse of atypical depression. The hypothesis is that modafinil is safe and effective in the treatment of atypical depression.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Duke University
Collaborator:
Cephalon
Treatments:
Armodafinil
Modafinil